| abstract |
The invention discloses a compound shown as a formula I or a stereoisomer, a pharmaceutically acceptable salt, a hydrate or a solvate thereof. The invention also discloses a preparation method and application of the compound. The compound shown in the formula I is an excellent AR inhibitor and is clinically screened and/orProvides a new choice for preparing the medicine for treating the prostatic cancer and has good application prospect. |